Synthesis of cyclooctapeptides: Constraints analogues of the peptidic neurotoxin, ω-agatoxine IVB - An experimental point of view

Journal of Peptide Science

Volumn 14, Issue 3, 2008, Pages 267-277

  Minta, Ewelina ^a   Kafarski, Pawel ^b   Martinez, Jean ^a   Rolland, Valérie ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

agatoxin IVB; On resin side chain to side chain lactam cyclization; P Q type calcium channels; Peptidic neurotoxins; SPPS

Indexed keywords

ALANINE; AMIDE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM CHANNEL STIMULATING AGENT; CYCLOPEPTIDE; GLUTAMIC ACID; LYSINE; MACROGOL; NEUROTOXIN; NINHYDRIN; OMEGA AGATOXIN; OMEGA AGATOXIN IVB; PIPERIDINE; RESIN; TRYPTOPHAN; UNCLASSIFIED DRUG;

AMINO ACID SYNTHESIS; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; CYCLIZATION; DRUG STRUCTURE; EXPERIMENTAL STUDY; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECRETION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; NEUROTOXINS; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PROTEIN CONFORMATION; SPIDER VENOMS; TRYPTOPHAN;

EID: 40749114327     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.919     Document Type: Article

References (32)

1. Lecointe L, Rolland-Fulcrand V, Pappalardo L, Roumestant ML, Viallefont Ph, Martinez J. Diastereoselective synthesis of non proteinogenic α-aminoacids. J. Pept. Res. 2000; 55(4): 300-307.
2. Wehbe J, Rolland V, Martinez J, Rolland M. Structural study of an intermediate in a new synthesis of β-hydroxy-β-substituted aspartate. Acta Crystallogr. 2003; C59: 473-475.
3. Wehbe J, Kassem T, Rolland V, Rolland M, Tabcheh M, Roumestant ML, Martinez J. Optically pure β-substituted-β-hydroxy aspartate as glutamate transporter blockers. Org. Biomol. Chem. 2003; 1: 1938-1942.
4. Wehbe J, Rolland V, Roumestant ML, Martinez J. Glutamate transporter blockers: enantiomerically pure (2S, 3S) and (2S, 3R) 3-methyl glutamic acids. Tetrahedron: Asymmetry 2003; 14: 1123-1126.
5. Wehbe J, Rolland V, Fruchier A, Roumestant ML, Martinez J. Enantioselective synthesis of new 4-substituted glutamic acid derivatives. Tetrahedron: Asymmetry 2004; 15: 851-858.
6. Kochegarov AA. Therapeutical application of voltage-gated calcium channel modulators. Expert Opin. Ther. Patents 2002; 12: 243-287.
7. Adams ME. Agatoxins: ion channel specific toxins from the american funnel web spider, Agelenopsis aperta. Toxicon 2000; 43: 509-525.
8. Mintz IM, Venema VJ, Swiderek KM, Lee TD, Bean BP, Adams ME. P-Type calcium channels blocked by the spider toxin ω-Aga-IV A. Nature 1992; 355(6363): 827-829.
9. Adams ME, Mintz IM, Reily MD, Thanabal V, Bean BP. Structure and properties of omega-agatoxin IVB, a new antagonist of P- type calcium channels. Mol. Pharmacol. 1993; 44(4): 681-688.
10. Reily MD, Thanabal V, Adams ME. The solution structure of omega-Aga-IVB, a type calciul channel antagonist from venom of the funnel web spider, aganelopsis aperta. J. Biomol. NMR 1995; 5(2): 122-132.
11. Turner TJ, Adams ME, Dunlap K. Calcium channels coupled to glutamate release identified by ω-Aga-IVA. Science 1992; 258(5080): 310-313.
12. Nishio H, Kumagaye KY, Kubo S, Chen Y, Momiyama A, Takahashi T, Kimura T, Sakakibara S. Synthesis of ω-agatoxin IVA and its related peptides. Biochem. Biophys. Res. Commun. 1993; 196(3): 1447-1453.
13. Najib J, Letailleur T, Gesquiere JC, Tartar A. Solid-phase synthesis of ω-agatoxin IVA, a P-type calcium channel blocker. J. Pept. Sci. 1996; 2(5): 309-317.
14. Davies JS. The cyclisation of peptides and depsipeptides. J. Pept. Sci. 2003; 9(8): 471-501.
15. Hargittai B, Sole NA, Groebe DR, Abramson SN, Barany G. Chemical syntheses and biological activities of lactam analogues of α-Conotoxin SI. J. Med. Chem. 2000; 43: 4787-4792.
16. Cavallaro V, Thompson P. Solid phase synthesis of cyclic peptides: model involving i-(i+4) side-chain-to-side-chain cyclisation. J. Pept. Sci. 1998; 4(5): 335-343.
17. Lundquist JT IV, Pelletier JC. A new tri-orthogonal strategy for peptide cyclisation. Org. Lett. 2002; 4: 3219-3221.
18. Lecointe L, Rolland-Fulcrand V, Roumestant ML, Viallefont Ph, Martinez J. Chemoenzymatic synthesis of two enantiomers of 7-azatryptophane. Tetrahedron: Asymmetry 1998; 9(10): 1753-1758.
19. Minta E, Boutonnet C, Boutard N, Martinez J, Rolland V. Easy saponification by metal silanolates: application in SPPS and in (S)-5-hydroxynorvaline preparation. Tetrahedron Lett. 2005; 46(11): 1795-1797.
20. Albericio F. Orthogonal protecting group for Nα-amino and C-terminal carboxyl functions in solid-phase peptide synthesis. Biopolymers 2000; 55(2): 123-139.
21. Guibe F. Allylic protecting groups and their use in a complex environment part I: allylic protection of alcohols. Tetrahedron 1997; 53(40): 13509-13556.
22. Guibe F. Allylic protecting groups and their use in a complex environment part II: allylic protecting groups and their removal through catalytic palladium π-allyl methodology. Tetrahedron 1998; 54: 2967-3042.
23. Tang YC, Xie HB, Tian GL, Ye YH. Synthesis of cyclopentapeptides and cycloheptapeptides by DEPT and the influence of some factors on cyclisation. J. Pept. Res. 2002; 60(2): 95-103.
24. Besser D, Olender R, Rosenfeld R, Arad O, Reissmann S. Study on the cyclization tendency of backbone cyclic tetrapeptides. J. Pept. Res. 2000; 56(6): 337-345.
25. Alcaro MC, Sabatino G, Uziel G, Chelli M, Ginanneschi M, Rovero P, Papini AM. On-resin head-to-tail cyclisation of cyclotetrapeptides: optimization of crucial parameters. J. Pept. Sci. 2004; 10: 218-228.
26. Cabrele C, Langer M, Beck-Sickinger AG. Amino acid side chain attachment approach and its application to the synthesis of tyrosine-containing cyclic peptides. J. Org. Chem. 1999; 64(12): 4353-4361.
27. Zhang W, Taylor JW. Efficient solid-phase synthesis of peptides with tripodal side-chain bridges and optimization of the solvent conditions for solid-phase cyclisations. Tetrahedron Lett. 1996; 37(13): 2173-2176.
28. Malesevic M, Strijowski U, Bachle B, Sewald N. An improved method for the solution cyclisation of peptides under pseudo-high dilution conditions. J. Biotechnol. 2004: 112(1-2): 73-77.
29. Kurome TK, Inami K, Inoue T, Ikai K, Takesado, K. Total synthesis of an antifungal cyclic depsipeptide aureobasidin A. Tetrahedron 1996; 52(12): 4327-4346.
30. Perlman ZE, Bock JE, Peterson JR, Lokey RS. Geometric diversity through permutation of backbone configuration in cyclic peptide libraries. Bioorg. Med. Chem. Lett. 2005; 15(23): 5329-5334.
31. Catterall WA, Striessnig J, Snutch TP, Perez-Reyes E. International union of pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels. Pharmacol. Rev. 2003; 55(4): 579-581.
32. Barrett CF, Cao YQ, Tsien RW. Gating deficiency in a familial hemiplegic migraine type 1 mutant P/Q-type calcium channel. J. Biol. Chem. 2005; 280(24): 24064-24071.